Sponsor Pipeline

Inhye Ahn Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
2
Active Trials
2
Recruiting
2
Disease Areas
Active Trials by Phase
Phase 2
1
Phase 1/2
1
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT06333262 Fixed Duration Pirtobrutinib and Obinutuzumab in Chronic Lymphocytic Leukemia Chronic Lymphocytic Leukemia Recruiting
Phase 1/2
NCT07052695 Mosunetuzumab for CLL MRD Clearance Leukemia Recruiting
Disease Areas
Leukemia (2) Chronic Lymphocytic Leukemia (CLL) (2)
Get alerts when Inhye Ahn's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free